These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis. Cheong JH; Yang HK; Kim H; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Kim HY; Lee J; Choi SH; Hong S; Kim JW; Choi YY; Hyung WJ; Jang E; Kim H; Huh YM; Noh SH Lancet Oncol; 2018 May; 19(5):629-638. PubMed ID: 29567071 [TBL] [Abstract][Full Text] [Related]
4. Development and validation of a nomogram with an epigenetic signature for predicting survival in patients with lung adenocarcinoma. Wang J; He L; Tang Y; Li D; Yang Y; Zeng Z Aging (Albany NY); 2020 Nov; 12(22):23200-23216. PubMed ID: 33221751 [TBL] [Abstract][Full Text] [Related]
5. Stratification of resectable lung adenocarcinoma by molecular and pathological risk estimators. Rakha E; Pajares MJ; Ilie M; Pio R; Echeveste J; Hughes E; Soomro I; Long E; Idoate MA; Wagner S; Lanchbury JS; Baldwin DR; Hofman P; Montuenga LM Eur J Cancer; 2015 Sep; 51(14):1897-903. PubMed ID: 26235745 [TBL] [Abstract][Full Text] [Related]
6. Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer. Li B; Cui Y; Diehn M; Li R JAMA Oncol; 2017 Nov; 3(11):1529-1537. PubMed ID: 28687838 [TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma. Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance and adjuvant chemotherapy survival benefits of a solid or micropapillary pattern in patients with resected stage IB lung adenocarcinoma. Qian F; Yang W; Wang R; Xu J; Wang S; Zhang Y; Jin B; Yu K; Han B J Thorac Cardiovasc Surg; 2018 Mar; 155(3):1227-1235.e2. PubMed ID: 29223834 [TBL] [Abstract][Full Text] [Related]
9. Impact of the 8th Edition of the UICC-TNM Classification on Clinical Stage 0-IA Lung Adenocarcinoma: Does the New Classification Predict Postoperative Prognosis More Precisely than the Previous One? Wang L; Anraku M; Sato M; Nitadori JI; Nagayama K; Kitano K; Nakajima J Ann Thorac Cardiovasc Surg; 2018 Oct; 24(5):223-229. PubMed ID: 29848840 [TBL] [Abstract][Full Text] [Related]
10. The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival. Warth A; Muley T; Meister M; Stenzinger A; Thomas M; Schirmacher P; Schnabel PA; Budczies J; Hoffmann H; Weichert W J Clin Oncol; 2012 May; 30(13):1438-46. PubMed ID: 22393100 [TBL] [Abstract][Full Text] [Related]
11. A gene expression-based single sample predictor of lung adenocarcinoma molecular subtype and prognosis. Liljedahl H; Karlsson A; Oskarsdottir GN; Salomonsson A; Brunnström H; Erlingsdottir G; Jönsson M; Isaksson S; Arbajian E; Ortiz-Villalón C; Hussein A; Bergman B; Vikström A; Monsef N; Branden E; Koyi H; de Petris L; Patthey A; Behndig AF; Johansson M; Planck M; Staaf J Int J Cancer; 2021 Jan; 148(1):238-251. PubMed ID: 32745259 [TBL] [Abstract][Full Text] [Related]
12. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis. Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208 [TBL] [Abstract][Full Text] [Related]
13. A three gene-based risk score predicts prognosis of resected non-small-cell lung cancer. Liu K; Chen HL; Gu MM; You QS Int J Clin Exp Pathol; 2015; 8(12):16081-8. PubMed ID: 26884885 [TBL] [Abstract][Full Text] [Related]
14. Immune landscape and a novel immunotherapy-related gene signature associated with clinical outcome in early-stage lung adenocarcinoma. Bao X; Shi R; Zhao T; Wang Y J Mol Med (Berl); 2020 Jun; 98(6):805-818. PubMed ID: 32333046 [TBL] [Abstract][Full Text] [Related]
15. Incorporation of a Molecular Prognostic Classifier Improves Conventional Non-Small Cell Lung Cancer Staging. Kratz JR; Haro GJ; Cook NR; He J; Van Den Eeden SK; Woodard GA; Gubens MA; Jahan TM; Jones KD; Kim IJ; He B; Jablons DM; Mann MJ J Thorac Oncol; 2019 Jul; 14(7):1223-1232. PubMed ID: 30959120 [TBL] [Abstract][Full Text] [Related]
16. The prognostic value of a Methylome-based Malignancy Density Scoring System to predict recurrence risk in early-stage Lung Adenocarcinoma. Yang L; Zhang J; Yang G; Xu H; Lin J; Shao L; Li J; Guo C; Du Y; Guo L; Li X; Han-Zhang H; Wang C; Chuai S; Ye J; Kang Q; Liu H; Ying J; Wang Y Theranostics; 2020; 10(17):7635-7644. PubMed ID: 32685009 [TBL] [Abstract][Full Text] [Related]
17. Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non-Small Cell Lung Cancer. Gentles AJ; Bratman SV; Lee LJ; Harris JP; Feng W; Nair RV; Shultz DB; Nair VS; Hoang CD; West RB; Plevritis SK; Alizadeh AA; Diehn M J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26286589 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival. He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781 [TBL] [Abstract][Full Text] [Related]
19. Prediction of distant recurrence in resected stage I and II lung adenocarcinoma. Aramini B; Casali C; Stefani A; Bettelli S; Wagner S; Sangale Z; Hughes E; Lanchbury JS; Maiorana A; Morandi U Lung Cancer; 2016 Nov; 101():82-87. PubMed ID: 27794412 [TBL] [Abstract][Full Text] [Related]
20. A Cost-Effectiveness Analysis of Using the JBR.10-Based 15-Gene Expression Signature to Guide Adjuvant Chemotherapy in Early Stage Non-Small-Cell Lung Cancer. Wong KM; Ding K; Li S; Bradbury P; Tsao MS; Der SD; Shepherd FA; Chung C; Ng R; Seymour L; Leighl NB Clin Lung Cancer; 2017 Jan; 18(1):e41-e47. PubMed ID: 27502323 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]